4.2 Article

Determining patient and primary care delay in the diagnosis of cancer - lessons from a pilot study of patients referred for suspected cancer

期刊

BMC FAMILY PRACTICE
卷 9, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/1471-2296-9-9

关键词

-

向作者/读者索取更多资源

Background: There is no validated way of measuring diagnostic delay in cancer, especially covering patient and primary care delays. An instrument is needed in order to determine the effect of potential interventions to reduce delay and improve cancer morbidity and mortality. Methods: Development of a postal questionnaire tool to measure patient and primary care time responses to key symptoms and signs. The pilot questionnaire was sent to 184 patients with suspected cancer. Results: The response rate was only 85/184 (46.2%). Anxiety was cited as one reason for this low response. Patients returning questionnaires were more likely to be women and more likely to be younger. 84/85 (98.8%) provided consent to access medical records, and questions regarding health profile, smoking and socio-economic profile were answered adequately. Outcome data on their cancer diagnosis was linked satisfactorily and the question about GP-initiated investigations was answered well. Estimated dates for symptom duration were preferred for patient delays, but exact dates were preferred for primary care delays; however there was a significant amount of missing data. Conclusion: A more personal approach to the collection of data about the duration of symptoms in this group of people is needed other than a postal questionnaire. However elements of this piloted questionnaire are likely to figure strongly in future development and evaluation of this tool.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Cancer care for people with dementia: Literature overview and recommendations for practice and research

Laura Ashley, Claire Surr, Rachael Kelley, Mollie Price, Alys Wyn Griffiths, Nicole R. Fowler, Dana E. Giza, Richard D. Neal, Charlene Martin, Jane B. Hopkinson, Anita O'Donovan, William Dale, Bogda Koczwara, Katie Spencer, Lynda Wyld

Summary: With the aging population, cancer patients are getting older and more likely to have preexisting comorbidities, such as dementia. People with dementia are vulnerable to health disparities, which can complicate cancer care and outcomes.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Article Medicine, General & Internal

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher C. Butler, F. D. Richard Hobbs, Oghenekome A. Gbinigie, Najib M. Rahman, Gail Hayward, Duncan B. Richards, Jienchi Dorward, David M. Lowe, Joseph F. Standing, Judith Breuer, Saye Khoo, Stavros Petrou, Kerenza Hood, Jonathan S. Nguyen-Van-Tam, Mahendra G. Patel, Benjamin R. Saville, Joe Marion, Emma Ogburn, Julie Allen, Heather Rutter, Nick Francis, Nicholas P. B. Thomas, Philip Evans, Melissa Dobson, Tracie-Ann Madden, Jane Holmes, Victoria Harris, May Ee Png, Mark Lown, Oliver van Hecke, Michelle A. Detry, Christina T. Saunders, Mark Fitzgerald, Nicholas S. Berry, Lazaro Mwandigha, Ushma Galal, Sam Mort, Bhautesh D. Jani, Nigel D. Hart, Haroon Ahmed, Daniel Butler, Micheal McKenna, Jem Chalk, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer C. Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Andrew Carson-Stevens, Ly-Mee Yu, Paul Little

Summary: This study aimed to determine the safety, effectiveness, and cost-effectiveness of molnupiravir in vaccinated high-risk patients in the community. The results showed that molnupiravir did not reduce hospital admissions or deaths associated with COVID-19 compared to usual care in this population.

LANCET (2023)

Article Oncology

Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study

Lesley Smith, Jonathan Carmichael, Gordon Cook, Bethany Shinkins, Richard D. Neal

Summary: This study developed an algorithm to identify individuals at high-risk of undiagnosed myeloma based on routine blood test results. Further testing can then be conducted to specifically diagnose myeloma. This method has the potential to significantly impact the diagnosis of myeloma on a large scale and at a low cost.

CANCERS (2023)

Article Public, Environmental & Occupational Health

Psychometric Properties of an Adapted Stigma Scale and Experiences of Stigma Associated with HIV Pre-exposure Prophylaxis Use Among Men Who have Sex with Men: A Mixed Methods Study

David Gillespie, Adam Williams, Fiona Wood, Zoe Couzens, Adam Jones, Richard Ma, Marijn de Bruin, Dyfrig A. A. Hughes, Kerenza Hood

Summary: This study investigated the experiences of HIV pre-exposure prophylaxis (PrEP) users in Wales (UK) with regards to PrEP-related stigma, and adapted an existing HIV stigma scale for this purpose. The measure showed good psychometric properties, but further refinement and validation are needed.

AIDS AND BEHAVIOR (2023)

Article Primary Health Care

Patients' views on the decision to investigate cancer symptoms in older adults: a qualitative interview study in primary care

Daniel Jones, Omer M. Ali, Stephanie Honey, Claire Surr, Suzanne Scott, Niek De Wit, Richard Neal

Summary: This qualitative study aimed to explore the views and experiences of older adults on various aspects of cancer investigation through semi-structured interviews. The study found that older adults preferred clarity on symptoms and diagnosis, even if it required unpleasant investigations. They expressed a desire to be involved in the decision-making process. It also highlighted the importance of not deferring or delaying referrals and investigations based on age or subjective assessments of frailty. Shared decision-making and involvement in the decision-making process were seen as important by patients, regardless of age.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Editorial Material Medicine, Research & Experimental

The importance of NOT being Other: Time to address the invisibility of nuanced gender and sexuality in clinical trials

Adam D. N. Williams, Kerenza Hood, Karen Bracken, Gillian W. Shorter

Summary: To ensure the applicability of trial evidence to the relevant population and the availability of effective interventions for all, it is crucial to include representation of all members of society in research, especially those typically underserved. However, the inadequate and unrepresentative options in demographic questions related to sex, gender, and sexuality may exclude LGBTQIA+ people from health research.

TRIALS (2023)

Article Medicine, Research & Experimental

Biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: statistical analysis plan for the BATCH trial and PRECISE sub-study

Simon M. Schoenbuchner, Chao Huang, Cherry-Ann Waldron, Emma Thomas-Jones, Kerenza Hood, Enitan D. Carrol, Philip Pallmann

Summary: The BATCH trial is a randomized trial comparing procalcitonin-guided management with current management for severe bacterial infection in children. The trial aims to assess the effectiveness of an additional procalcitonin test in guiding antibiotic prescribing decisions.

TRIALS (2023)

Article Multidisciplinary Sciences

Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers

Wai Hoong Chang, Richard D. Neal, Martin D. Forster, Alvina G. Lai

Summary: This study evaluated the burden of 144 health conditions and critical care admissions in 243,767 adults with 26 adult cancers and treatment modalities. The top conditions by fold difference in cumulative burden in survivors compared to controls were haematology, immunology/infection, and pulmonary conditions. Patients receiving chemotherapy, radiotherapy, and surgery had a higher burden of late morbidities compared to those receiving radiotherapy alone. The top five cancers with the highest cumulative burden of critical care admissions were bone, brain, spinal cord and nervous system, testis, and Hodgkin lymphoma.

NATURE COMMUNICATIONS (2023)

Article Medicine, General & Internal

Symptoms and signs of lung cancer prior to diagnosis: case-control study using electronic health records from ambulatory care within a large US-based tertiary care centre

Maria G. Prado, Larry G. Kessler, Margaret A. Au, Hannah A. Burkhardt, Monica Zigman Suchsland, Lesleigh Kowalski, Kari A. Stephens, Meliha Yetisgen, Fiona M. Walter, Richard D. Neal, Kevin Lybarger, Caroline A. Thompson, Morhaf Al Achkar, Elizabeth A. Sarma, Grace Turner, Farhood Farjah, Matthew J. Thompson

Summary: This study found that lung cancer patients often have symptoms and signs recorded in the electronic health records in the USA, and these symptoms and signs often appear 6 months or more before diagnosis. These findings provide opportunities for early diagnosis of lung cancer.

BMJ OPEN (2023)

Article Medicine, General & Internal

Impact of the COVID-19 pandemic on domiciliary care workers in Wales, UK: a data linkage cohort study using the SAIL Databank

Rebecca Cannings-John, Simon Schoenbuchner, Hywel Jones, Fiona V. Lugg-Widger, Ashley Akbari, Lucy Brookes-Howell, Kerenza Hood, Ann John, Daniel Rh Thomas, Hayley Prout, Michael Robling

Summary: The study aimed to quantify the population health risks for domiciliary care workers (DCWs) in Wales, UK, during the COVID-19 pandemic. The results showed that the confirmed and suspected COVID-19 infection rates increased over time, reaching 24% by November 30, 2021. The study also found that DCWs had a higher burden of mental health conditions compared to the pre-pandemic period.

BMJ OPEN (2023)

Article Infectious Diseases

Perspectives of Statistician, Microbiologist, and Clinician Stakeholders on the Use of Microbiological Outcomes in Randomised Trials of Antimicrobial Stewardship Interventions

Tin Man Mandy Lau, Rhian Daniel, Kerenza Hood, Mandy Wootton, Kathryn Hughes, Beth Stuart, Gail Hayward, Tamas Szakmany, David Gillespie

Summary: Microbiological data are often used in clinical trials for infection indicators, diagnosis, and antimicrobial resistance identification. However, a systematic review has identified problems in the use and reporting of these data, leading to a need for understanding and improvement. Discussions were held with key stakeholders to address issues raised in the review and explore alternative statistical approaches. Factors contributing to the low quality of microbiological outcomes were identified, highlighting the importance of researchers understanding the impact of misusing these data.

ANTIBIOTICS-BASEL (2023)

Article Microbiology

Gaining an Understanding of Pneumocystosis in Wales

Jonathan Ayling-Smith, Matthijs Backx, Elizabeth Grant, Rishi Dhillon, Jamie Duckers, Kerenza Hood, P. Lewis White

Summary: PcP is a serious complication of immunocompromising conditions. This study in Wales aimed to determine the incidence of PcP using laboratory reporting measures and assess its impact on mortality. The study found an incidence rate of 1.23-1.26 cases per 100,000, higher than previous estimates. The mortality rate was high in non-HIV patients regardless of immunosuppression cause, highlighting the need for increased awareness and early diagnosis.

JOURNAL OF FUNGI (2023)

Article Medicine, General & Internal

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Oghenekome Gbinigie, Emma Ogburn, Julie Allen, Jienchi Dorward, Melissa Dobson, Tracie-Ann Madden, Ly-Mee Yu, David M. Lowe, Najib Rahman, Stavros Petrou, Duncan Richards, Kerenza Hood, Mahendra Patel, Benjamin R. Saville, Joe Marion, Jane Holmes, May Ee Png, Gail Hayward, Mark Lown, Victoria Harris, Bhautesh Jani, Nigel Hart, Saye Khoo, Heather Rutter, Jem Chalk, Joseph F. Standing, Judith Breuer, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Nick Francis, Nicholas P. B. Thomas, Philip Evans, Oliver van Hecke, Mona Koshkouei, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Jonathan Nguyen-Van-Tam, Andrew Carson-Stevens, Richard Hobbs, Paul Little, Christopher C. Butler

Summary: This study is a clinical trial that aims to evaluate the safety, effectiveness, and cost-effectiveness of novel antiviral treatments for COVID-19 in vaccinated patients at increased risk in the community. It is an open-label, prospective, adaptive, multiarm platform trial that allows for the addition of new treatments and the evaluation of existing interventions. The study also includes a prospective economic evaluation.

BMJ OPEN (2023)

Review Geriatrics & Gerontology

Identifying barriers and facilitators to the inclusion of older adults living in UK care homes in research: a scoping review

Brittany Nocivelli, Victoria Shepherd, Kerenza Hood, Carolyn Wallace, Fiona Wood

Summary: A scoping review was conducted to explore barriers and facilitators to including older people living in UK care homes in research. The findings identified recurring barriers and facilitators and highlighted the need to address both direct and indirect factors in order to increase the evidence-base for care provided to older people living in care homes.

BMC GERIATRICS (2023)

Article Oncology

Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial

Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D. Neal, Tim Planche, Kamaraj Karunanithi, Stephen Jenkins, Simon Stern, Sarah Arnott, Peter Toth, Farooq Wandroo, Janet Dunn, Mark T. Drayson

Summary: Myeloma, a rare and hard-to-diagnose blood cancer, often leads to irreversible organ damage by the time of diagnosis. Patients rarely describe 'bone pain', but rather 'pain'. Vertebral fractures are under-recognized as abnormal and are the most common form of irreversible organ damage. Screening based on certain symptoms, combined with imaging and laboratory results, may speed up myeloma diagnosis.

CANCERS (2023)

暂无数据